Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial
In the version of the article initially published, in the “Phase 1a dose escalation” column in Fig. 2, the fifth dose was listed as “0.054 mg” but should have been “0.54 mg”. This correction has been made to the HTML and PDF versions of the article.
Authors
- Daniel Heudobler (ORCID: https://orcid.org/0000-0002-8790-4584)
- Mathias Haenel
- Heiko Becker (ORCID: https://orcid.org/0000-0002-6919-4048)
- Ольга Веремчук (ORCID: https://orcid.org/0000-0003-3298-7076)
- Farastuk Bozorgmehr (ORCID: https://orcid.org/0000-0001-8058-8884)
- Stefan Knop (ORCID: https://orcid.org/0000-0003-1276-6639)
- Carsten Reinhardt (ORCID: https://orcid.org/0000-0003-2905-1920)
- Annalen Bleckmann (ORCID: https://orcid.org/0000-0001-5809-9507)
- Meike Hutt (ORCID: https://orcid.org/0000-0002-5696-2140)
- Stefanie Groepper
- Sebastian Ochsenreither (ORCID: https://orcid.org/0000-0001-6024-4312)
- Martin Wermke (ORCID: https://orcid.org/0000-0002-4844-4087)
- Cedrik M. Britten (ORCID: https://orcid.org/0000-0003-3424-8760)
- Silvia Spoerl
- Max‐Felix Häring
- Simon Laban (ORCID: https://orcid.org/0000-0001-6732-7137)
- Judith S. Hecker (ORCID: https://orcid.org/0000-0002-1531-0517)
- Manuel Ruh (ORCID: https://orcid.org/0000-0003-1815-3024)
- Norbert Hilf (ORCID: https://orcid.org/0000-0002-2618-8174)
- Manik Chatterjee (ORCID: https://orcid.org/0000-0001-7854-5543)
- Dirk Jaeger (ORCID: https://orcid.org/0000-0002-1276-7802)
- Sarah Missel
- Andrea Mayer-Mokler
- Martin Hofmann (ORCID: https://orcid.org/0000-0002-8870-6512)
- Moritz Kleemiss
- Martin Sebastian
- Heiko Schuster
Institutions
- Goethe University Frankfurt (DE)
- Heidelberg University (DE)
- University Hospital Bonn (DE)
- University Medical Center Freiburg (DE)
- University Hospital Heidelberg (DE)
- TUM Klinikum (DE)
- University Hospital Regensburg (DE)
- Universitätsklinikum Erlangen (DE)
- Nuremberg Hospital (DE)
- Comprehensive Cancer Center Mainfranken (DE)
- University Hospital Münster (DE)
- National Center for Tumor Diseases (DE)
- University Children's Hospital Tübingen (DE)
- Marien Hospital Düsseldorf (DE)
- Immatics Biotechnologies (Germany) (DE)
- Frankfurt Cancer Institute (DE)
- Klinikum Chemnitz (DE)
- Technical University of Munich (DE)
- Technische Universität Dresden (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Nature Medicine
- Published
- 2026-06-19
- DOI
- https://doi.org/10.1038/s41591-026-04519-y
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00